
Sign up to save your podcasts
Or


Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
By Forbes India3.5
1212 ratings
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India

7,723 Listeners

531 Listeners

408 Listeners

286 Listeners

1,108 Listeners

11 Listeners

56 Listeners

87 Listeners

41 Listeners

41 Listeners

4 Listeners

15 Listeners

9 Listeners

95 Listeners

13 Listeners